26 May 2013
Keywords: merck, aids, drug, research, stumbles, co, suffered
Article | 07 March 1994
Merck & Co has suffered a severe setback for its AIDS research program
for the protease inhibitor L-735,524 with the discovery ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
7 March 1994
24 May 2013
© 2013 thepharmaletter.com